BitGenetic is dedicated to deciphering the language of DNA to offer clear and precise answers in healthcare. Its mission is to apply cutting-edge genetics to clinical diagnostics and personal well-being, transforming complex genomic data into useful and actionable information.
Its main technology is Next-Generation Sequencing (NGS), which it applies through complete exome (Whole Exome Sequencing, WES) and genome (Whole Genome Sequencing, WGS) analysis. This approach allows for detecting with maximum resolution single nucleotide variants (Single Nucleotide Variants, SNV), as well as insertions/deletions (Indels) and large genomic rearrangements (Copy Number Variants, CNV). Thanks to this powerful capability, BitGenetic offers a complete portfolio of genetic services:
BitGenetic drives a vision where genetics and technology converge to create truly personalized medicine. Its goal is to be a key ally in healthcare, providing reliable and accessible diagnostics that empower patients and professionals and open the door to a future with more effective treatments.
José Bayón, dir. public affairs GDELS
Gonzalo León, executive committee Innovative Companies Forum
Micaela Martelli, Director of Sectorial Solutions Telefónica
Blanca Caballero, CEO Nanological
Carolina Gago, COO IOT Lenses
Amalio Garrido, CEO Drage&Mate
Mª Jesús Romero, dir. of economy and industry, Madrid City Council
Marina Villegas, General Director of Research and Technological Innovation Community of Madrid
Mª Inmaculada López, Director Compluemprende
Eduardo Díaz, Director of EBT Office Fund. Madri+d
Luis Baratas, head of entrepreneurship sector, ICEX